Acceptability of the reusable SurePal™ self-injection device for Omnitrope(®) among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter observational study

BACKGROUND: SurePal™ is a reusable self-injection system that has been developed to support daily administration of Omnitrope(®) (Sandoz, Kundl, Austria). A questionnaire-based cross-sectional survey was conducted to evaluate acceptability of, and preference for, SurePal™ in pediatric patients who w...

Descripción completa

Detalles Bibliográficos
Autores principales: Partsch, Carl-Joachim, Schnabel, Dirk, Ehtisham, Sarah, Johnstone, Helen C, Zabransky, Markus, Kiess, Wieland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578482/
https://www.ncbi.nlm.nih.gov/pubmed/26405430
http://dx.doi.org/10.2147/MDER.S93209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578482/
https://www.ncbi.nlm.nih.gov/pubmed/26405430
http://dx.doi.org/10.2147/MDER.S93209

Ejemplares similares